Penicillin production to begin in 2019
Production of Rostec company Ruselectronics’ Penicillin artillery reconnaissance system will begin in early 2019, the company announced on 11 May.
According to the company state trials of the system are now nearing completion.
The Penicillin system is designed to detect the firing positions of enemy artillery, mortars, multiple launch rocket systems, anti-aircraft and tactical missiles, and adjust responsive artillery fire.
Mounted aboard a Kamaz-6350 chassis, the mobile system can operate in a combat radius up to 25km. The system consists of a 1B75 electro-optical module, which works in the infrared and visible spectrum using imaging cameras placed on a telescopic boom, and several ground-installed 1B76 sound and seismic receivers.
The system can operate in an unmanned mode for precise artillery reconnaissance without risking the lives of army personnel.
More from Land Warfare
-
US Army seeks nearly $900 million to accelerate development and acquisition of CUAS capabilities
The branch plans to speed up the building and procurement of kinetic and non-kinetic systems for fixed, semi-fixed and on-the-move operations.
-
Large 10×10 vehicles go in search of a role
Wheeled vehicles ranging in size from 4×4 to 8×8 provide high-speed at a good level of mobility compared to tracked. However, tracked can be larger and have a higher level of mobility in marginal terrain with a smaller turning circle. What are the possibilities for a 10×10?
-
Borsuk IFV programme marks turning point for Poland’s armoured modernisation
The Borsuk vehicles are to replace the Soviet-designed BMP-1 as the Polish military’s main tracked Infantry Fighting Vehicle (IFV).
-
DroneShield nets largest order ever with $40 million European CUAS contract
The package of three standalone follow-on contracts makes this the largest contract won by the Australian company and larger than its total 2024 revenue.
-
US Army modernisation plans raise big concerns for lawmakers
The termination of programmes such as JLTV and RCV has been harshly criticised by members of the US Congress.